Buradasınız

GATA Acil Dahiliye Kliniğinde üst gastrointestinal sistem kanaması nedeniyle 1998-2005 yılları arasında takip edilen hastaların sosyodemografik özelliklerinin incelenmesi

Analysis of the sociodemographic characteristics of the patients followed-up with the diagnosis of upper gastrointestinal bleeding at the Department of Emergency Internal Medicine of GATA between 1998 to 2005

Journal Name:

Publication Year:

Abstract (2. Language): 
Upper gastrointestinal system bleeding is a commonly encountered medical emergency with significant morbidity and mortality. In this study we aimed to retrospectively analyze the sociodemographic characteristics of the patients we followed-up with the diagnosis of upper gastrointestinal system bleeding between 1998 to 2005. Of approximately 7000 cases admitting to the Department of Emergency of GATA during the study period, 898 cases diagnosed to have upper gastrointestinal system bleeding were included in the study. The mean age of the patients was was 52.5±21.3 years (16- 103 years). Of all the patients 480 were male (53.5%) and 418 were female (46.5%), and 335 were married (37.3%) and 563 were single (62.7%). Of the cases most (n=350) were military persons' family (39%). When analyzed according to educational status, most of the people (241 cases) graduated from high school (26.8%). When the patients were examined according to endoscopic diagnoses, cases with duodenal ulcer (n=289) were the largest group (32.2%). Number of cases with first bleeding was 636 (70.8%). Mean hospitalization period of the patients was 4.1±6.2 days. Socio-demographic characteristics of the patients play an important role in mortality and morbidity of the patients with upper gastrointestinal system bleeding. Our results are in accordance with the literature findings.
Abstract (Original Language): 
Üst gastrointestinal sistem kanamaları, anlamlı ölüm oranı ve morbiditeleriyle sık karşılaşılan tıbbi bir acildir. Bu çalışmada üst gastrointestinal sistem kanaması nedeniyle 1998- 2005 yılları arasında takip ettiğimiz hastaların sosyodemografik özelliklerini retrospektif olarak incelemeyi amaçladık. Çalışma süresince GATA acil servisine başvuran yaklaşık 7000 hastadan, üst gastrointestinal sistem kanaması tanısı konmuş 898 hasta çalışmaya alındı. Hastaların ortalama yaşı 52.5±21.3 yıl idi (16-103 yıl). Hastaların 480'i erkek (%53.5), 418'i kadındı (%46.5) ve 335 hasta evli (%37.3), 563 hasta bekardı (%62.7). Olgularda en büyük grubu 350 hasta (%39) ile asker aileleri oluşturmaktaydı. Öğrenim durumlarına göre incelendiğinde, lise mezunu olanlar 241 olgu ile (%26.8) en yüksek grubu oluşturmaktaydı. Endoskopik tanılarına göre hastalar incelendiğinde en büyük grubu 289 olgu ile (%32.2) duodenal ülser tanısı konan olgular oluşturmaktaydı. İlk kez kanama geçiren olguların sayısı 636 (%70.8) olarak saptandı. Hastaların ortalama yatış süresi 4.1±6.2 gün idi. Hastaların sosyodemografik özellikleri üst gastrointestinal sistem kanamalarının ölüm oranı ve morbiditesinde önemli rol oynamaktadır. Bizim sonuçlarımız bu doğrultuda literatürle uyumlu bulunmuştur.
226-231

REFERENCES

References: 

1. Kayaçetin E., Polat H. Üst gastrointestinal sistem kanamalarý: 52 vakanýn incelenmesi. Genel Týp Dergisi 2003;
13: 119-122.
2. Laine L. Acute and chronic gastrointestinal bleeding. In:
Feldman M, Scharschmidt BF, Sleisenger MH (eds).
Gastrointestinal and Liver Disease. 4th ed. Philadelphia:
WB Saunders Company, 1998: 198-210.
3. Jutabha R, Jensen DM. Acute upper gastrointestinal
bleeding. In: Friedman SL, McQuaid KR, Grendell JH
(eds). Current Diagnosis & Treatment in Gastroenterology. 2nd ed. New York: McGraw-Hill Co, 2003: 53-69.
4. Dimmitt L, Dimmitt S, Wilson G. Diagnosis of gastrointestinal bleeding in adults. Am Fam Physician 2005; 71:
1339-1346.
5. Wilcox CM, Clark WS. Causes and outcome of upper andCilt 49 · Sayý 4 · Gülhane TD Üst gastrointestinal kanamalý hastalar · 231
lower gastrointestinal bleeding: the Grady Hospital experience. South Med J 1999; 92: 44-50.
6. Yavorski RT, Wong RK, Maydonovitch C, Battin LS,
Furnia A, Amundson DE. Analysis of 3,294 cases of upper
gastrointestinal bleeding in military medical facilities. Am
J Gastroenterol 1995; 90: 568-573.
7. Vreeburg EM, Snel P, de Bruijne JW, Bartelsman JF,
Rauws EA, Tytgat GN. Acute upper gastrointestinal
bleeding in the Amsterdam area: incidence, diagnosis, and
clinical outcome. Am J Gastroenterol 1997; 92: 236-243.
8. Longstreth GF. Epidemiology and outcome of patients
hospitalized with acute lower gastrointestinal hemorrhage: a population-based study. Am J Gastroenterol
1997; 92: 419-424.
9. Das A, Wong RCK. Prediction of outcome of acute GI
hemorrhage: a review of risk scores and predictive models. Gastrointest Endosc 2004; 60: 85-93.
10. Gralnek IM. Outpatient management of low-risk nonvariceal upper GI hemorrhage. Are we ready to put evidence
into practice. Gastrointest Endosc 2002; 55: 131-134.
11. Memik F. Peptik ülser komplikasyonlarý. In: Memik F
(ed). Her Yönüyle Peptik Ülser. Ýstanbul: Nobel Týp
Kitapevleri, 2003: 105-112.
12. Pulanic R, Vucelic B, Rosandic M. Comparison of infection sclerotherapy and laser photocoagulation for bleeding
peptic ulcers. Endoscopy 1995; 27: 291-297.
13. Alican F. Abdomen: genel konular. Cerrahi Dersleri. 2.
baský. Cilt 1. Ýstanbul: Avrupa Týp Kitapçýlýk, 1998: 419-
491.
14. Peter DJ, Dougherty JM. Evaluation of the patient with
gastrointestinal bleeding: an evidence based approach.
Emerg Med Clin North Am 1999; 17: 239-261.
15. Maltz C. Acute gastrointestinal bleeding. Best Practice of
Medicine. February 2003: 1-19.
16. Katschinski B, Logan R., Davies J. Prognostic factors in
upper gastrointestinal bleeding. Dig Dis Sci 1994; 39:
706-712.
17. Silverstein FE, Gilbert DA, Tedesco FJ, Buenger NK,
Persing J. The national ASGE survey on upper gastrointestinal bleeding. I. Study desing and baseline data.
Gastrointest Endosc 1981; 27: 73-79.
18. Loperfido S, Monica F, Maifreni L. Bleeding peptic ulcer
occuring in hospitalized patients: analysis of predictive
and risk factors and comparison without of hospital onset
hemorrhage. Dig Dis Sci 1994; 39: 698-705.
19. Sugawa C, Steffes CP, Nakamura R. Upper gastrointestinal bleeding in an urban hospital. Ann Surg 1990; 212:
521-527.
20. Baer PG, Cagen L. Renal prostaglandin excretion and
metabolism in male and female New Zealand normotensive and genetically hypertensive rats. Hypertension 1984;
3: 257-261.
21. Hawkey CJ. Synthesis of prostaglandin E2, thromboxane
B2, and prostaglandin catabolism in gastritis and gastric
ulcer. Gut 1986; 27: 1484-1492.
22. Cryer B, Goldschmiedt M. Gastric and duodenal mucosal prostaglandin concentration in gastric and duodenal
ulcer disease: relationship with demographics, enviromental and histologic factors, including Helicobacter
Pylori. Am J Gastroenterol 1992; 87: 1747-1754.
23. Wong RKH, Majumdar A. Effect of castration and estradiol on hemorrhagic gastritis (HG) and gastric mucosal
cellular proliferation (CP) in male rats. Gastroentrology
1988; 94: A502.
24. Johnston SJ, Jones PF, Kyle J, Needham CD. Epidemiology and course of gastrointestinal haemorrhage in
North-east Scotland. Br Med J 1973; 29: 655-660.
25. Törüner M. Gastrointestinal hastalýklarýn belirtileri.
Geçim ÝE (ed). Cerrahinin Ýlkeleri. 1. Baský. Ankara:
Antýp, 2004: 1053-1100.
26. Hamoui N, Docherty SD, Crookes PF. Gastrointestinal
hemorrhage: is the surgeon obsolete. Emerg Med Clin
North Am 2003; 21: 1017-1056.
27. Sönmez MF, Ozan E. Açlýk ve açlýk sonrasý doyurulmanýn
sýçan mide dokusu üzerine etkileri: ýþýk mikroskobik çalýþ-
ma. Fýrat Týp Dergisi 2005; 10: 96-102.
28. Martin DF, Montgomeny E, Dobek AS, et al. Campylobacter pylori. NSAIDs and smoking: risk factors for
peptic ulcer disease. Am J Gastroenterol 1989; 84: 1268-
1272.
29. Sokic-Milutinovic A, Krstic M, Popovic D, et al. Role of
Helicobacter pylori infection and use of NSAIDs in the
etiopathogenesis of upper gastrointestinal bleeding. Acta
Chir Iugosl 2007; 54: 51-62.
30. Garcia Rodriguez LA, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual
non-steroidal anti-inflamatory drugs. Lancet 1994; 343:
769-772.

Thank you for copying data from http://www.arastirmax.com